Cargando…
What matters: non-pharmaceutical interventions for COVID-19 in Europe
OBJECTIVES: The purpose of this study is to describe the situation of COVID-19 in European countries and to identify important factors related to prevention and control. METHODS: We obtained data from World Health Statistics 2020 and the Institute for Health Metrics and Evaluation (IHME). We calcula...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743060/ https://www.ncbi.nlm.nih.gov/pubmed/35000583 http://dx.doi.org/10.1186/s13756-021-01039-x |
_version_ | 1784629827808002048 |
---|---|
author | Liu, Yan Yu, Qiuyan Wen, Haoyu Shi, Fang Wang, Fang Zhao, Yudi Hong, Qiumian Yu, Chuanhua |
author_facet | Liu, Yan Yu, Qiuyan Wen, Haoyu Shi, Fang Wang, Fang Zhao, Yudi Hong, Qiumian Yu, Chuanhua |
author_sort | Liu, Yan |
collection | PubMed |
description | OBJECTIVES: The purpose of this study is to describe the situation of COVID-19 in European countries and to identify important factors related to prevention and control. METHODS: We obtained data from World Health Statistics 2020 and the Institute for Health Metrics and Evaluation (IHME). We calculated the Rt values of 51 countries in Europe under different prevention and control measures. We used lasso regression to screen factors associated with morbidity and mortality. For the selected variables, we used quantile regression to analyse the relevant influencing factors in countries with different levels of morbidity or mortality. RESULTS: The government has a great influence on the change in Rt value through prevention and control measures. The most important factors for personal and group prevention and control are the mobility index, testing, the closure of educational facilities, restrictions on large-scale gatherings, and commercial restrictions. The number of ICU beds and doctors in medical resources are also key factors. Basic sanitation facilities, such as the proportion of safe drinking water, also have an impact on the COVID-19 epidemic. CONCLUSIONS: We described the current status of COVID-19 in European countries. Our findings demonstrated key factors in individual and group prevention measures. |
format | Online Article Text |
id | pubmed-8743060 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-87430602022-01-10 What matters: non-pharmaceutical interventions for COVID-19 in Europe Liu, Yan Yu, Qiuyan Wen, Haoyu Shi, Fang Wang, Fang Zhao, Yudi Hong, Qiumian Yu, Chuanhua Antimicrob Resist Infect Control Research OBJECTIVES: The purpose of this study is to describe the situation of COVID-19 in European countries and to identify important factors related to prevention and control. METHODS: We obtained data from World Health Statistics 2020 and the Institute for Health Metrics and Evaluation (IHME). We calculated the Rt values of 51 countries in Europe under different prevention and control measures. We used lasso regression to screen factors associated with morbidity and mortality. For the selected variables, we used quantile regression to analyse the relevant influencing factors in countries with different levels of morbidity or mortality. RESULTS: The government has a great influence on the change in Rt value through prevention and control measures. The most important factors for personal and group prevention and control are the mobility index, testing, the closure of educational facilities, restrictions on large-scale gatherings, and commercial restrictions. The number of ICU beds and doctors in medical resources are also key factors. Basic sanitation facilities, such as the proportion of safe drinking water, also have an impact on the COVID-19 epidemic. CONCLUSIONS: We described the current status of COVID-19 in European countries. Our findings demonstrated key factors in individual and group prevention measures. BioMed Central 2022-01-09 /pmc/articles/PMC8743060/ /pubmed/35000583 http://dx.doi.org/10.1186/s13756-021-01039-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Liu, Yan Yu, Qiuyan Wen, Haoyu Shi, Fang Wang, Fang Zhao, Yudi Hong, Qiumian Yu, Chuanhua What matters: non-pharmaceutical interventions for COVID-19 in Europe |
title | What matters: non-pharmaceutical interventions for COVID-19 in Europe |
title_full | What matters: non-pharmaceutical interventions for COVID-19 in Europe |
title_fullStr | What matters: non-pharmaceutical interventions for COVID-19 in Europe |
title_full_unstemmed | What matters: non-pharmaceutical interventions for COVID-19 in Europe |
title_short | What matters: non-pharmaceutical interventions for COVID-19 in Europe |
title_sort | what matters: non-pharmaceutical interventions for covid-19 in europe |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743060/ https://www.ncbi.nlm.nih.gov/pubmed/35000583 http://dx.doi.org/10.1186/s13756-021-01039-x |
work_keys_str_mv | AT liuyan whatmattersnonpharmaceuticalinterventionsforcovid19ineurope AT yuqiuyan whatmattersnonpharmaceuticalinterventionsforcovid19ineurope AT wenhaoyu whatmattersnonpharmaceuticalinterventionsforcovid19ineurope AT shifang whatmattersnonpharmaceuticalinterventionsforcovid19ineurope AT wangfang whatmattersnonpharmaceuticalinterventionsforcovid19ineurope AT zhaoyudi whatmattersnonpharmaceuticalinterventionsforcovid19ineurope AT hongqiumian whatmattersnonpharmaceuticalinterventionsforcovid19ineurope AT yuchuanhua whatmattersnonpharmaceuticalinterventionsforcovid19ineurope |